Q2 2021 Archives - Angus Reid Institute

Q2 2021

Vaccine Passports: Canadians show strong support for use in international travel, fewer willing to comply at home

Personal concern over contracting COVID-19 dips, but even vaccinated Canadians remain anxious May 26, 2021 – As some provinces loosen community restrictions and unveil post-pandemic reopening plans, Canadians may be forgiven for day-dreaming about future days of free movement and

COVID-19: Seven-in-ten oppose sharing vaccines globally until vaccinations in Canada are complete

Vaccine hesitation remains highest in AB and SK, where one-in-five opposed to or unsure of inoculation June 14, 2021 – Under pressure at the G-7 summit to reveal how much of Canada’s pledge to share 100 million doses of COVID-19

Long-term Care in Canada: For those with family in LTC facilities during COVID-19 pandemic, size mattered

Relatives of LTC residents offer more praise to smaller, privately run homes in handling pandemic May 25, 2021 – It has been more than a year since COVID-19 outbreaks first tore through many long-term care facilities in this country, resulting

Despite months of mixed messages, most Canadians who received an AstraZeneca vaccine have no regrets

Vaccine hesitancy plunges to three per cent, but one-tenth of population remain unwilling to be jabbed May 17, 2021 – As the rate of Canadians who have been vaccinated with at least one-dose of a COVID-19 vaccine surges to more

What we’re learning from COVID-19 could help us confront climate change

By Shachi Kurl, President As Canadians navigate byzantine vaccination systems, fight for paid sick days, and grieve for otherwise healthy loved ones some of whom are now, horrifyingly, dying alone in their sleep, COVID-19 robs us of something more still:

Vaccine Vacillation: Confidence in AstraZeneca jumps amid increased eligibility; trust in Johnson & Johnson tumbles

Hesitancy remains highest in Alberta where 28 per cent say they will not be vaccinated or remain unsure April 26, 2021 – An extraordinary period in which Xennials and Generation-Xers became eligible for AstraZeneca doses in several provinces (and in

1 2